Sionna Therapeutics (SION)
7.18
+0.43 (6.37%)
Upcoming Events
Latest Headlines
Freedom Broker Downgrades Sionna Therapeutics (SION) to Hold
August 11, 2026 10:09 AM - StreetInsider
Jones Trading Downgrades Sionna Therapeutics (SION) to Hold
August 10, 2026 3:53 PM - StreetInsider
LifeSci Capital Downgrades Sionna Therapeutics (SION) to Market Perform
August 10, 2026 3:21 PM - StreetInsider
BTIG Downgrades Sionna Therapeutics (SION) to Neutral, 'we were wrong on our PreciSION CF call'
August 10, 2026 3:14 PM - StreetInsider
Guggenheim Downgrades Sionna Therapeutics (SION) to Neutral
August 10, 2026 1:15 PM - StreetInsider
RBC Capital Upgrades Sionna Therapeutics (SION) to Sector Perform
August 10, 2026 11:46 AM - StreetInsider
Citizens Downgrades Sionna Therapeutics (SION) to Market Perform
August 10, 2026 11:45 AM - StreetInsider
Raymond James Downgrades Sionna Therapeutics (SION) to Market Perform
August 10, 2026 11:44 AM - StreetInsider
Wedbush Downgrades Sionna Therapeutics (SION) to Neutral
August 10, 2026 10:42 AM - StreetInsider
Vertex stock jumps as rival cystic fibrosis drug fails trial
August 10, 2026 10:01 AM - StreetInsider
Stifel Downgrades Sionna Therapeutics (SION) to Hold
August 10, 2026 9:22 AM - StreetInsider
Tenax, Sionna plunge; MarineMax jumps premarket on reported buyout
August 10, 2026 8:04 AM - StreetInsider
Form 8-K Sionna Therapeutics, For: Aug 10
August 10, 2026 7:15 AM - SEC Filing
Sionna CF drug trial fails key endpoint; company halts program
August 10, 2026 7:00 AM - StreetInsider
Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update
August 10, 2026 7:00 AM - StreetInsider
Sionna Therapeutics (SION) PT Raised to $59 at Raymond James
August 6, 2026 10:24 AM - StreetInsider
Sionna Therapeutics (SION) Misses Q2 EPS by 14c
August 6, 2026 8:51 AM - StreetInsider
Form 10-Q Sionna Therapeutics, For: Jun 30
August 6, 2026 7:20 AM - SEC Filing
Form 8-K Sionna Therapeutics, For: Aug 06
August 6, 2026 7:13 AM - SEC Filing
Sionna Therapeutics Reports Second Quarter 2026 Financial Results
August 6, 2026 7:01 AM - Globe NewsWire
Form 4 Sionna Therapeutics, For: Jul 07 Filed by: Thompson Peter A.
July 9, 2026 4:48 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Jul 07 Filed by: ORBIMED ADVISORS LLC
July 9, 2026 4:44 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Jul 06 Filed by: Fitzpatrick Jennifer
July 7, 2026 4:38 PM - SEC Filing
Form 144 Sionna Therapeutics, Filed by: Fitzpatrick Jennifer
July 6, 2026 4:40 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Jun 30 Filed by: Thompson Peter A.
July 2, 2026 4:45 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Jun 30 Filed by: ORBIMED ADVISORS LLC
July 2, 2026 4:42 PM - SEC Filing
Sionna Therapeutics (SION) Reiterated at Market Outperform by Citizens: Readouts Upcoming
June 23, 2026 4:36 AM - StreetInsider
Form 4 Sionna Therapeutics, For: Jun 17 Filed by: Stelzer Laurie
June 18, 2026 5:58 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Jun 17 Filed by: Viney Joanne L.
June 18, 2026 5:48 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Jun 17 Filed by: Thompson Peter A.
June 18, 2026 5:46 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Jun 17 Filed by: RA Capital Nexus Fund, L.P.
June 18, 2026 5:42 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Jun 17 Filed by: Ruddy Marcella K.
June 18, 2026 5:39 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Jun 17 Filed by: Resnick Joshua
June 18, 2026 5:37 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Jun 17 Filed by: Fleming Harold Edward
June 18, 2026 5:36 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Jun 17 Filed by: Clancy Paul J
June 18, 2026 5:33 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Jun 17 Filed by: Booth Bruce
June 18, 2026 5:29 PM - SEC Filing
Form 8-K Sionna Therapeutics, For: Jun 17
June 18, 2026 4:06 PM - SEC Filing
Full Article List
